We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Breakthrough AI-Based Quantitative Brain Imaging in MR to Advance Neurology Care

By MedImaging International staff writers
Posted on 04 Mar 2024
Print article
Image: Smart Quant Neuro 3D combines the 3D SyntAc clinical application and SyMRI NEURO 3D (Photo courtesy of SyntheticMR)
Image: Smart Quant Neuro 3D combines the 3D SyntAc clinical application and SyMRI NEURO 3D (Photo courtesy of SyntheticMR)

Diagnosing brain injuries and neurodegenerative diseases is a complex task for clinicians due to the varying symptoms presented by patients. Precise evaluation of brain tissue volume and distribution is crucial for diagnosing these conditions. Traditional visual assessments of MRI images often lack accuracy and objectivity, making it challenging to measure tissue volume from 2D slices. Now, a breakthrough technology automatically measures various brain tissues, aiding in the diagnosis, progression assessment, and therapy monitoring of brain diseases.

Royal Philips (Amsterdam‎, Noord-Holland) and SyntheticMR (Linköping, Sweden) have launched Smart Quant Neuro 3D. This innovative tool significantly enhances decision-making in diagnosing and assessing therapies for brain disorders such as multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. Smart Quant Neuro 3D integrates Philips' AI-based SmartSpeed image-reconstruction technology, its 3D SyntAc clinical application, and SyntheticMR's SyMRI NEURO 3D quantitative tissue assessment software. This integration equips healthcare providers with robust tools for more confident diagnoses, ultimately benefiting patients. Philips' exclusive agreement with SyntheticMR makes it the only company currently able to offer SyMRI NEURO 3D capability on MR scanners.

Utilizing AI, Smart Quant Neuro 3D delivers verified, automatic, and precise 3D segmentation and volume measurement of brain tissues such as white matter, gray matter, cerebrospinal fluid, and myelin. These measurements, when analyzed by a trained physician, can provide valuable insights for patient diagnosis. Clinicians can use Smart Quant Neuro 3D to obtain quantitative data, track treatment impacts, and guide adjustments or alternative interventions. This continuous monitoring improves patient care by allowing proactive management of neurological conditions and optimizing treatment outcomes. Smart Quant Neuro 3D is particularly adept at measuring myelin, crucial for the proper transmission of electrical impulses in the brain. Myelin loss is a key indicator of TBI, and Smart Quant Neuro 3D's ability to detect currently invisible abnormalities on conventional MR scans aids in early diagnosis and intervention.

Quantifying myelin loss is also vital in progressive diseases like MS, helping clinicians assess the condition, monitor its progression, and evaluate the effectiveness of disease-modifying drugs. Patients also benefit from Smart Quant Neuro 3D as it provides all necessary clinical MR imaging contrasts from a single acquisition, eliminating the need for additional scans. Philips' AI-based MR SmartSpeed reconstruction technology enhances imaging speed by nearly three times and improves resolution by up to 65%, facilitating patient scanning and potentially increasing radiology department throughput. SyntheticMR's SyMRI NEURO 3D software then conducts an automatic analysis of the imaging data, accurately segmenting and measuring tissue volume in less than 10 seconds of post-processing.

 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
New
Breast Imaging Workstation
SecurView
New
Pre-Op Planning Solution
Sectra 3D Trauma

Print article
Radcal

Channels

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.